Skip to main content
All lobbying filings

CHILDREN'S HEALTHCARE OF ATLANTA

Lobbying for CHILDREN'S HEALTHCARE OF ATLANTA

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $100,000.00 expenses · posted Mar 16, 2026

Official filing document

 Bills named in this filing 2
  • HR 2107
    Children’s Hospital GME Support Reauthorization Act of 2025
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 2
Health Issues

Medicaid program Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally HR 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Federal telehealth policy generally

Budget/Appropriations

Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies. Department of Health and Human Services programs regarding autism and sickle cell disease research Fiscal Year 2025 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 1 (One Big Beautiful Bill Act) Sections 71115, 71116, regarding Medicaid financing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem